DCDerek A. T. Cummings

Derek A. T. Cummings

*This is an algorithmically generated author record based on publicly available information.

Derek A. T. Cummings has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Potential opportunities and perils of imperfect dengue vaccines

    by Isabel Rodriguez-Barraquer, Luis Mier-Y-Teran-Romero, Ira B. Schwartz, Donald S. Burke, Derek A.T. Cummings


  • Open Access

    Revisiting Rayong: Shifting Seroprofiles of Dengue in Thailand and Their Implications for Transmission and Control

    by Isabel Rodríguez-Barraquer, Rome Buathong, Sopon Iamsirithaworn, Ananda Nisalak, Justin Lessler, Richard G. Jarman, Robert V. Gibbons, Derek A.T. Cummings

    Dengue virus has traditionally caused substantial morbidity and mortality among children less than 15 years of age in Southeast Asia. Over the last 2 decades, a significant increase in the mean age of cases has been reported, and a once pediatric disease now causes substantial burden among the adult population. An age-stratified serological study (n = 1,736) was conducted in 2010 among schoolchildren in the Mueang Rayong district of Thailand, where a similar study had been conducted in 1980/1981. Serotype-specific forces of infection (λ(t)) and basic reproductive numbers (R0) of dengue were estimated for the periods 1969–1980 and 1993–2010. Despite a significant increase in the age at exposure and a decrease in λ(t) from 0.038/year to 0.019/year, R0 changed only from 3.3 to 3.2. Significant heterogeneity was observed across subdistricts and schools, with R0 ranging between 1.7 and 6.8. These findings are consistent with the idea that the observed age shift might be a consequence of the demographic transition in Thailand. Changes in critical vaccination fractions, estimated by using R0, have not accompanied the increase in age at exposure. These results have implications for dengue control interventions because multiple countries in Southeast Asia are undergoing similar demographic transitions. It is likely that dengue will never again be a disease exclusively of children.


  • Open Access

    Incubation periods of viral gastroenteritis: a systematic review

    by Rachel M Lee, Justin Lessler, Rose A Lee, Kara E Rudolph, Nicholas G Reich, Trish M Perl, Derek At Cummings

    Background: Accurate knowledge of incubation period is important to investigate and to control infectious diseases and their transmission, however statements of incubation period in the literature are often uncited, inconsistent, and/or not evidence based.Methods: In a systematic review of the literature on five enteric viruses of public health importance, we found 256 articles with incubation period estimates, including 33 with data for pooled analysis.Results: We fit a log-normal distribution to pooled data and found the median incubation period to be 4.5 days (95% CI 3.9-5.2 days) for astrovirus, 1.2 days (95% CI 1.1-1.2 days) for norovirus genogroups I and II, 1.7 days (95% CI 1.5-1.8 days) for sapovirus, and 2.0 days (95% CI 1.4-2.4 days) for rotavirus.Conclusions: Our estimates combine published data and provide sufficient quantitative detail to allow for these estimates to be used in a wide range of clinical and modeling applications. This can translate into improved prevention and control efforts in settings with transmission or the risk of transmission.


  • Jumping Germs

    by Derek Cummings

  • The incubation period of cholera: A systematic review

    by Andrew S. Azman, Kara E. Rudolph, Derek A.T. Cummings, Justin Lessler


  • Open Access

    Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis

    by Kaitlin Rainwater-Lovett, Isabel Rodriguez-Barraquer, Derek At Cummings, Justin Lessler

    Background: The plaque reduction neutralization test (PRNT) remains the gold standard for the detection of serologic immune responses to dengue virus (DENV). While the basic concept of the PRNT remains constant, this test has evolved in multiple laboratories, introducing variation in materials and methods. Despite the importance of laboratory-to-laboratory comparability in DENV vaccine development, the effects of differing PRNT techniques on assay results, particularly the use of different dengue strains within a serotype, have not been fully characterized.Methods: We conducted a systematic review and pooled analysis of published literature reporting individual-level PRNT titers to identify factors associated with heterogeneity in PRNT results and compared variation between strains within DENV serotypes and between articles using hierarchical models.Results: The literature search and selection criteria identified 8 vaccine trials and 25 natural exposure studies reporting 4,411 titers from 605 individuals using 4 different neutralization percentages, 3 cell lines, 12 virus concentrations and 51 strains. Of 1,057 titers from primary DENV exposure, titers to the exposure serotype were consistently higher than titers to non-exposure serotypes. In contrast, titers from secondary DENV exposures (n = 628) demonstrated high titers to exposure and non-exposure serotypes. Additionally, PRNT titers from different strains within a serotype varied substantially. A pooled analysis of 1,689 titers demonstrated strain choice accounted for 8.04% (90% credible interval [CrI]: 3.05%, 15.7%) of between-titer variation after adjusting for secondary exposure, time since DENV exposure, vaccination and neutralization percentage. Differences between articles (a proxy for inter-laboratory differences) accounted for 50.7% (90% CrI: 30.8%, 71.6%) of between-titer variance.Conclusions: As promising vaccine candidates arise, the lack of standardized assays among diagnostic and research laboratories make unbiased inferences about vaccine-induced protection difficult. Clearly defined, widely accessible reference reagents, proficiency testing or algorithms to adjust for protocol differences would be a useful first step in improving dengue PRNT comparability and quality assurance.


  • Revealing the microscale spatial signature of dengue transmission and immunity in an urban population

    by Henrik Salje, Justin Lessler, Timothy P. Endy, Frank C. Curriero, Robert V. Gibbons, Ananda Nisalak, Suchitra Nimmannitya, Siripen Kalayanarooj, Richard G. Jarman, Stephen J. Thomas, et al.

    It is well-known that the distribution of immunity in a population dictates the future incidence of infectious disease, but this process is generally understood at individual or macroscales. For example, herd immunity to multiple pathogens has been observed at national and city levels. However, the effects of population immunity have not previously been shown at scales smaller than the city (e.g., neighborhoods). In particular, no study has shown long-term effects of population immunity at scales consistent with the spatial scale of person-to-person transmission. Here, we use the location of dengue patients’ homes in Bangkok with the serotype of the infecting pathogen to investigate the spatiotemporal distribution of disease risk at small spatial scales over a 5-y period. We find evidence for localized transmission at distances of under 1 km. We also observe patterns of spatiotemporal dependence consistent with the expected impacts of homotypic immunity, heterotypic immunity, and immune enhancement of disease at these distances. Our observations indicate that immunological memory of dengue serotypes occurs at the neighborhood level in this large urban setting. These methods have broad applications to studying the spatiotemporal structure of disease risk where pathogen serotype or genetic information is known.


  • Open Access

    Design and Analysis of Vaccine Studies: By M. Elizabeth Halloran, Ira M. Longini, Jr., and Claudio J. Struchiner

    by Derek A. T. Cummings, Justin Lessler

    Vaccines act to control infectious diseases through multiple mechanisms. Vaccines can reduce susceptibility to infection, progression to symptomatic disease, and the probability that vaccinees will infect others. Vaccines directly protect vaccinees but also provide protection to persons around them by reducing their risk of acquisition. In Design and Analysis of Vaccine Studies, 3 pioneers in the statistical analysis of infectious disease, Elizabeth Halloran, Ira M. Longini, and Claudio Struchiner, present an excellent and comprehensive introduction to a growing methodology aimed at teasing apart the many effects of vaccines. The goal of this work has been to develop a more precise formalism and methods that are not subject to the same threats to validity as standard epidemiologic methods—that is, to develop an approach that succeeds where methods that ignore the infectious process fail. This collective effort has led to an exemplar of nomenclature and clarity of thinking that should be of interest to researchers in all fields. This text provides the clearest summary of this body of work to date, complementing texts covering the practical aspects of field trial design.


  • Open Access

    Location-specific patterns of exposure to recent pre-pandemic strains of influenza A in southern China

    by Justin Lessler, Derek A.T. Cummings, Jonathan M. Read, Shuying Wang, Huachen Zhu, Gavin J.D. Smith, Yi Guan, Chao Qiang Jiang, Steven Riley

    Variation in influenza incidence between locations is commonly observed on large spatial scales. It is unclear whether such variation occurs on smaller spatial scales and whether it is the result of heterogeneities in population demographics or more subtle differences in population structure and connectivity. Here we show that significant differences in immunity to influenza A viruses among communities in China are not explained by differences in population demographics. We randomly selected households from five randomly selected locations near Guangzhou, China to answer a questionnaire and provide a blood sample for serological testing against five recently circulating influenza viruses. We find a significant reduction in the frequency of detectable neutralization titers with increasing age, levelling off in older age groups. There are significant differences between locations in age, employment status, vaccination history, household size and housing conditions. However, after adjustment, significant variations in the frequency of detectable neutralization titers persists between locations. These results suggest there are characteristics of communities that drive influenza transmission dynamics apart from individual and household level risk factors, and that such factors have effects independent of strain.


  • Models of the impact of dengue vaccines: A review of current research and potential approaches

    by Michael A. Johansson, Joachim Hombach, Derek A.T. Cummings